The emerging role of high-dose-rate brachytherapy for prostate cancer

Clinical Oncology

Volumn 17, Issue 4, 2005, Pages 219-227

  Morton, Gerard C ^a  

^a DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

Author keywords

Conformal; Dose rate; Fractionation; Interstitial; Prostate neoplasms

Indexed keywords

BRACHYTHERAPY; CANADA; CANCER CONTROL; CANCER GRADING; CANCER RISK; CANCER SURVIVAL; CLINICAL TRIAL; HUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIOBIOLOGY; REVIEW; TREATMENT OUTCOME; UNITED STATES; URETHRA STRICTURE;

EID: 19144370826     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2004.12.005     Document Type: Article

References (41)

1. L. Potters E.A. Klein M.W. Kattan et al. Monotherapy for stage T1-T2 prostate cancer: Radical prostatectomy, external beam radiotherapy, or permanent seed implantation Radiother Oncol 71 2004 29-33
2. M.J. Zelefsky Z. Fuks M. Hunt et al. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer J Urol 166 2001 876-881
3. A. Pollack G.K. Zagars G. Starkschall et al. Prostate cancer radiation dose response: Results of the MD Anderson phase III randomized trial Int J Radiat Oncol Biol Phys 53 2002 1097-1105
4. H. Lukka P. Warde T. Pickles et al. Controversies in prostate cancer radiotherapy: Consensus development Can J Urol 8 2001 1314-1322
5. J. Crook H. Lukka L. Klotz et al. Systematic overview of the evidence for brachytherapy in clinically localized prostate cancer CMAJ 164 2001 975-981
6. L. Potters Permanent prostate brachytherapy in men with clinically localised prostate cancer Clin Oncol 15 2003 301-315
7. D. Ash A. Flynn J. Battermann et al. ESTRO/EAU/EORTC recommendations on permanent seed implantation for localized prostate cancer Radiother Oncol 57 2000 315-321
8. J.Z. Wang X.A. Li C.X. Yu S.J. DiBiase The low alpha/beta ratio for prostate cancer: What does the clinical outcome of HDR brachytherapy tell us? Int J Radiat Oncol Biol Phys 57 2003 1101-1108
9. D.J. Brenner A.A. Martinez G.K. Edmundson et al. Direct evidence that prostate tumors show high sensitivity to fractionation (low alpha/beta ratio), similar to late-responding normal tissue Int J Radiat Oncol Biol Phys 52 2002 6-13
10. J. Fowler R. Chappell M. Ritter Is alpha/beta for prostate tumors really low? Int J Radiat Oncol Biol Phys 50 2001 1021-1031
11. J.F. Fowler M.A. Ritter R.J. Chappell D.J. Brenner What hypofractionated protocols should be tested for prostate cancer? Int J Radiat Oncol Biol Phys 56 2003 1093-1104
12. A.E. Nahum B. Movsas E.M. Horwitz et al. Incorporating clinical measurements of hypoxia into tumor local control modeling of prostate cancer: Implications for the alpha/beta ratio Int J Radiat Oncol Biol Phys 57 2003 391-401
13. I.C. Hsu B. Pickett K. Shinohara et al. Normal tissue dosimetric comparison between HDR prostate implant boost and conformal external beam radiotherapy boost: Potential for dose escalation Int J Radiat Oncol Biol Phys 46 2000 851-858
14. J. Pouliot Y. Kim E. Lessard et al. Inverse planning for HDR prostate brachytherapy used to boost dominant intraprostatic lesions defined by magnetic resonance spectroscopy imaging Int J Radiat Oncol Biol Phys 59 2004 1196-1207
15. Y. Kim I.C. Hsu E. Lessard et al. Dosimetric impact of prostate volume change between CT-based HDR brachytherapy fractions Int J Radiat Oncol Biol Phys 59 2004 1208-1216
16. A.M. Syed A. Puthawala et al. A Sharma High-dose-rate brachytherapy in the treatment of carcinoma of the prostate Cancer Control 8 2001 511-521
17. T.P. Mate J.E. Gottesman J. Hatton et al. High dose-rate afterloading 192Iridium prostate brachytherapy: Feasibility report Int J Radiat Oncol Biol Phys 41 1998 525-533
18. T. Martin C. Kolotas T. Dannenberg et al. New interstitial HDR brachytherapy technique for prostate cancer: CT based 3D planning after transrectal implantation Radiother Oncol 52 1999 257-260
19. C. Menard R.C. Susil P. Choyke et al. MRI-guided HDR prostate brachytherapy in standard 1.5T scanner Int J Radiat Oncol Biol Phys 59 2004 1414-1423
20. G. Kovacs R. Galalae Fractionated perineal high-dose-rate temporary brachytherapy combined with external beam radiation in the treatment of localized prostate cancer: Is lymph node sampling necessary? Cancer Radiother 7 2003 100-106
21. A.A. Martinez G. Gustafson J. Gonzalez et al. Dose escalation using conformal high-dose-rate brachytherapy improves outcome in unfavorable prostate cancer Int J Radiat Oncol Biol Phys 53 2002 316-327
22. G. Borghede H. Hedelin S. Holmang et al. Combined treatment with temporary short-term high dose rate iridium-192 brachytherapy and external beam radiotherapy for irradiation of localized prostatic carcinoma Radiother Oncol 44 1997 237-244
23. S. Deger D. Boehmer I. Turk et al. High dose rate brachytherapy of localized prostate cancer Eur Urol 41 2002 420-426
24. A.C. Pellizzon W. Nadalin J.V. Salvajoli et al. Results of high dose rate afterloading brachytherapy boost to conventional external beam radiation therapy for initial and locally advanced prostate cancer Radiother Oncol 66 2003 167-172
25. D.J. Demanes R.R. Rodriguez G.A. Altieri et al. High dose rate prostate brachytherapy: The California Endocurietherapy (CET) method Radiother Oncol 57 2000 289-296
26. T. Martin S. Roddiger R. Kurek et al. 3D conformal HDR brachytherapy and external beam irradiation combined with temporary androgen deprivation in the treatment of localized prostate cancer Radiother Oncol 71 2004 35-41
27. M.J. Curran G.A. Healey W. Bihrle III et al. Treatment of high-grade low-stage prostate cancer by high-dose-rate brachytherapy J Endourol 14 2000 351-356
28. J. Hiratsuka Y. Jo K. Yoshida et al. Clinical results of combined treatment conformal high-dose-rate iridium-192 brachytherapy and external beam radiotherapy using staging lymphadenectomy for localized prostate cancer Int J Radiat Oncol Biol Phys 59 2004 684-690
29. P.H. Chiang F.M. Fang W.C. Jong et al. High-dose rate iridium-192 brachytherapy and external beam radiation therapy for prostate cancer with or without androgen ablation Int J Urol 11 2004 152-158
30. P.J. Hoskin P.J. Bownes P. Ostler et al. High dose rate afterloading brachytherapy for prostate cancer: Catheter and gland movement between fractions Radiother Oncol 68 2003 285-288
31. E. Mullokandov G. Gejerman Analysis of serial CT scans to assess template and catheter movement in prostate HDR brachytherapy Int J Radiat Oncol Biol Phys 58 2004 1063-1071
32. S.J. Damore A.M. Syed A.A. Puthawala A. Sharma Needle displacement during HDR brachytherapy in the treatment of prostate cancer Int J Radiat Oncol Biol Phys 46 2000 1205-1211
33. S. Nag Gupta A simple method of obtaining equivalent doses for use in HDR brachytherapy Int J Radiat Oncol Biol Phys 46 2000 507-513
34. T. Martin D. Baltas R. Kurek et al. 3-D conformal HDR brachytherapy as monotherapy for localized prostate cancer. A pilot study Strahlenther Onkol 180 2004 225-232
35. Y. Yoshioka T. Nose K. Yoshida et al. High-dose-rate interstitial brachytherapy as a monotherapy for localized prostate cancer: Treatment description and preliminary results of a phase I/II clinical trial Int J Radiat Oncol Biol Phys 48 2000 675-681
36. I.S. Grills A.A. Martinez M. Hollander et al. High dose rate brachytherapy as prostate cancer monotherapy reduces toxicity compared to low dose rate palladium seeds J Urol 171 2004 1098-1104
37. A.A. Martinez I. Pataki G. Edmundson et al. Phase II prospective study of the use of conformal high-dose-rate brachytherapy as monotherapy for the treatment of favorable stage prostate cancer: A feasibility report Int J Radiat Oncol Biol Phys 49 2001 61-69
38. A. Martinez R. Galalae J. Gonzalez et al. No apparent benefit at 5 years from a course of neoadjuvant/concurrent androgen deprivation for patients with prostate cancer treated with a high total radiation dose J Urol 170 2003 2296-2301
39. G. Borghede H. Hedelin S. Holmang et al. Irradiation of localized prostatic carcinoma with a combination of high dose rate iridium-192 brachytherapy and external beam radiotherapy with three target definitions and dose levels inside the prostate gland Radiother Oncol 44 1997 245-250
40. A.C. Pellizzon J.V. Salvajoli M.A. Maia et al. Late urinary morbidity with high dose prostate brachytherapy as a boost to conventional external beam radiation therapy for local and locally advanced prostate cancer J Urol 171 2004 1105-1108
41. R.M. Galalae A. Martinez T. Mate et al. Long-term outcome by risk factors using conformal high-dose-rate brachytherapy (HDR-BT) boost with or without neoadjuvant androgen suppression for localized prostate cancer Int J Radiat Oncol Biol Phys 58 2004 1048-1055